Xiaoping Xing
- Nephrology top 0.5%
- Parathyroid Disorders and Treatments 77
-
- Bone health and osteoporosis research 56
- Oncology top 2%
- Bone health and treatments 72
- Genetics top 2%
- Connective tissue disorders research 44
- Genetic Syndromes and Imprinting 28
- Rheumatology top 2%
-
- Vitamin D Research Studies 24
-
- Bone Metabolism and Diseases 22
-
- Neuroendocrine Tumor Research Advances 20
- Journals
- Osteoporosis International (21 papers)Calcified Tissue International (18 papers)The Journal of Clinical Endocrinology & Metabolism (15 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xiaoping Xing
281 papers receiving 3.7k citations
Peers
Comparison fields: 5 of 136
- Nephrology 948
- Orthopedics and Sports Medicine 678
- Oncology 999
- Genetics 875
- Rheumatology 465
Countries citing papers authored by Xiaoping Xing
This map shows the geographic impact of Xiaoping Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Xing more than expected).
Fields of papers citing papers by Xiaoping Xing
This network shows the impact of papers produced by Xiaoping Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Xing. The network helps show where Xiaoping Xing may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaoping Xing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 1 | |
| 10 | 2022 | 1 | |
| 11 | 2022 | 0 | |
| 12 | 2021 | 2 | |
| 13 | 2021 | 2 | |
| 14 | 2017 | 13 | |
| 15 | 2015 | 28 | |
| 16 | 2014 | 11 | |
| 17 | Expression of Ki-67, galectin-3, fragile histidine triad, and parafibromin in malignant and benign parathyroid tumors. | 2012 | 29 |
| 18 | 2012 | 42 | |
| 19 | Generalized glucocorticoid resistance accompanied with an adrenocortical adenoma and caused by a novel point mutation of human glucocorticoid receptor gene. | 2011 | 22 |
| 20 | 2007 | 3 |
About Xiaoping Xing
Xiaoping Xing is a scholar working on Nephrology, Orthopedics and Sports Medicine, Oncology, Genetics and Rheumatology, having authored 298 papers that have together received 3.8k indexed citations. Recurring topics across this work include Parathyroid Disorders and Treatments (77 papers), Bone health and treatments (72 papers), Bone health and osteoporosis research (56 papers), Connective tissue disorders research (44 papers), Genetic Syndromes and Imprinting (28 papers), Vitamin D Research Studies (24 papers), Bone Metabolism and Diseases (22 papers) and Neuroendocrine Tumor Research Advances (20 papers). The work is most often cited by research in Nephrology (948 citations), Orthopedics and Sports Medicine (678 citations), Oncology (999 citations), Genetics (875 citations) and Rheumatology (465 citations). Xiaoping Xing has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Weibo Xia, Yan Jiang, Ou Wang, Mei Li, Xunwu Meng, Min Nie, Fang Lv, Dingrong Zhong, Wei Yu and Mei Li. Their work appears in journals such as Osteoporosis International, Calcified Tissue International, The Journal of Clinical Endocrinology & Metabolism, Frontiers in Endocrinology and Endocrine Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.